We’re on the cusp of a gene editing revolution, are we ready?
By Editorial,
New Scientist
| 07. 27. 2016
THERE’S a certain breed of techno-optimist who likes to talk about “the singularity” – a time when technology progresses so rapidly that life is transformed beyond recognition. The driving force of this hypothetical event is artificial intelligence, but biotech plays a key role too.
...
But there are dangers ahead – not least the science outpacing public consent. Two teams in China have already tried to engineer human embryos. That seems unnecessarily hasty given the ethical issues it raises.
Those who work on CRISPR have a duty to consider not just the science but also how it will be received. As yet, CRISPR has hardly registered in public debate.
Image via Pixabay
Related Articles
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...
By Katherine Long, Wall Street Journal | 07.31.2026
Kyla Simpson pulled up to the St. Johns County, Fla., sheriff’s office in a black SUV in June with two toddlers in the back seat. She had given birth to them and raised them.
“Mommy loves you, OK?” she said...
By Jessica Hamzelou, MIT Technology Review | 07.23.2026
When it comes to organ donation, time is everything. As soon as an organ has been carefully removed from a donor’s body, it starts to deteriorate. Surgeons have a matter of hours to get it into a recipient. Leave...
By Sophie Ryall , BioNews | 08.03.2026
A fertility doctor is being sued for using his own sperm during artificial insemination procedures without the patient's knowledge or consent.
Dr Dennis Lutz used his own sperm repeatedly when treating patient Jean Ann Nelson at the Medical Arts Clinic...